- Ireland
- Our innovation
- Clinical trials
Clinical trials
At Johnson & Johnson Innovative Medicine, we are committed to improving clinical trials for patients, trial sites, and investigators. By exploring new approaches and technologies, we aim to enhance patient participation, streamline drug development, and reduce associated costs.
We actively engage in open collaboration, seeking innovative solutions and sharing best practices with the wider healthcare community. Our aim is to contribute to the broader advancement of clinical research.
Clinical trials in Ireland
In Ireland, we recognise the importance of clinical trials in supporting research excellence and patient access to investigational medicines. We work closely with the Irish scientific community to facilitate clinical trials, contributing to the growth of research and development in the country.
Additionally, Johnson & Johnson is involved in Ireland’s first clinical trial in CAR-T therapy for multiple myeloma, an investigational treatment for certain blood cancers.
Additionally, Johnson & Johnson is involved in Ireland’s first clinical trial in CAR-T therapy for multiple myeloma, an investigational treatment for certain blood cancers.